Aesthetic Injectable Market
According to Intent Market Research, the Aesthetic Injectable Market is expected to grow from USD 11.8 billion in 2023 at a CAGR of 10.7% to touch USD 24.2 billion by 2030. The Aesthetic Injectable Market is dominated by key players such as Allergan, BioPlus Co., Ltd., Bloomage Biotechnology Corporation Limited, Croma-Pharma GmbH, Daewoong Pharmaceutical Co., Ltd., Eris Lifesciences Limited, Hugel, Inc., Ipsen, Medytox, Inc., Revance Therapeutics, Inc., RevitaLash Cosmetics, Sinclair Pharma and Teoxane SA.